Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Parkinson Disease*/metabolism ; Parkinson Disease*/drug therapy ; Parkinson Disease*/therapy ; Parkinson Disease*/etiology ; Signal Transduction*; Humans ; Animals ; Oxidative Stress ; alpha-Synuclein/metabolism

Parkinson's disease (PD) is considered the second most common neurodegenerative disease worldwide; treating this disease remains quite challenging. Environmental and genetic factors may play a role in the pathophysiology of PD. α-synuclein aggregation, oxidative stress, ferroptosis, mitochondrial failure, neuroinflammation, and gut dysbiosis are among the known risk factors of PD. The pathophysiology of Parkinson's disease is complicated by the interconnections between these molecular pathways, which also present significant obstacles to treatment development. However, due to its complex mechanism and long latency, PD is difficult to diagnose and detect, which presents a barrier to treatment. In addition, the need to develop new treatments for PD is increased by the fact that the majority of traditional therapeutic methods have major side effects and limited effects. Therefore, a deeper understanding of the fundamental mechanisms underlying PD is required. This review provides a comprehensive analysis of the current landscape of PD pathophysiology, paying particular attention to the molecular processes of PD, as well as the traditional research models, clinical diagnostic standards, documented medication therapeutic approaches, and recently disclosed drug candidates in clinical trials. We also highlighted the herbal-derived components that have recently been identified for their effects in the treatment of PD to provide a review and perspectives for the development of the next generation of drugs and preparations for the treatment of PD.

Food Funct. 2021 Sep 20;12(18):8366-8375. (PMID: 34342315)
Mov Disord. 2005 Feb;20(2):190-9. (PMID: 15551331)
J Biol Chem. 2002 May 3;277(18):16116-23. (PMID: 11850416)
Adv Neurol. 2003;91:29-37. (PMID: 12449099)
Lancet Neurol. 2007 Jul;6(7):652-62. (PMID: 17582365)
Mol Neurobiol. 2016 Mar;53(2):1181-1194. (PMID: 25598354)
Cell Death Differ. 2009 Mar;16(3):449-64. (PMID: 19023330)
Redox Biol. 2021 Nov;47:102134. (PMID: 34600334)
Curr Opin Cell Biol. 2008 Aug;20(4):427-36. (PMID: 18472259)
Autophagy. 2013 Nov 1;9(11):1801-17. (PMID: 24149440)
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7633-7639. (PMID: 30536304)
Neurosci Lett. 2017 Jan 10;637:50-56. (PMID: 27894919)
Autophagy. 2012 Jan;8(1):98-108. (PMID: 22113202)
Trends Microbiol. 2001 Mar;9(3):113-4. (PMID: 11303500)
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8968-73. (PMID: 12084935)
Neurosci Lett. 2013 Apr 29;541:93-8. (PMID: 23428505)
JAMA. 2014 Apr 23-30;311(16):1670-83. (PMID: 24756517)
Neurology. 2016 Apr 5;86(14 Suppl 1):S3-12. (PMID: 27044648)
J Biol Chem. 2003 Jul 18;278(29):27144-8. (PMID: 12743117)
Lancet. 2014 Aug 9;384(9942):532-44. (PMID: 24954673)
J Neural Transm (Vienna). 2017 Sep;124(9):1037-1054. (PMID: 28620835)
Ann N Y Acad Sci. 2008 Dec;1147:37-52. (PMID: 19076429)
Int J Neuropsychopharmacol. 2020 Aug 06;:. (PMID: 32761175)
Neurotox Res. 2019 Jul;36(1):12-26. (PMID: 30949950)
Signal Transduct Target Ther. 2023 Feb 21;8(1):73. (PMID: 36810524)
Brain. 2020 Jul 1;143(7):2220-2234. (PMID: 32613234)
Cell Mol Life Sci. 2012 Apr;69(7):1153-65. (PMID: 21984601)
J Cell Biol. 2010 Apr 19;189(2):211-21. (PMID: 20404107)
Front Immunol. 2017 Sep 26;8:1166. (PMID: 29018440)
Mov Disord. 2015 Jan;30(1):114-20. (PMID: 25476691)
Swiss Med Wkly. 2012 Aug 17;142:w13659. (PMID: 22903797)
J Pharm Bioallied Sci. 2014 Jan;6(1):2-9. (PMID: 24459397)
Neurobiol Dis. 2014 Mar;63:1-11. (PMID: 24269733)
Exp Neurol. 2008 Aug;212(2):431-9. (PMID: 18547564)
Neurotox Res. 2017 Jul;32(1):71-81. (PMID: 28285346)
Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283-99. (PMID: 22118895)
Gene. 2007 Oct 1;400(1-2):158-65. (PMID: 17651920)
J Clin Neurosci. 2019 Jun;64:242-251. (PMID: 30905662)
Acta Neuropathol Commun. 2021 Feb 17;9(1):27. (PMID: 33597025)
J Neurosci. 2010 Sep 15;30(37):12535-44. (PMID: 20844148)
Int J Mol Sci. 2014 Jan 22;15(1):1625-46. (PMID: 24451142)
Neurobiol Dis. 2006 Mar;21(3):541-8. (PMID: 16298531)
Lancet. 1977 Feb 26;1(8009):439-43. (PMID: 65560)
Neurosci Lett. 1994 Jan 3;165(1-2):208-10. (PMID: 8015728)
Mov Disord. 2014 Nov;29(13):1583-90. (PMID: 24976103)
Mov Disord. 2020 Jan;35(1):20-33. (PMID: 31680318)
Ann Neurol. 2005 Feb;57(2):168-75. (PMID: 15668962)
Science. 2012 Nov 16;338(6109):949-53. (PMID: 23161999)
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):445-453. (PMID: 29411055)
Exp Gerontol. 2019 Sep;124:110653. (PMID: 31295526)
Mov Disord. 2015 May;30(6):770-9. (PMID: 25900096)
Behav Brain Res. 2019 Jul 23;367:10-18. (PMID: 30922940)
Neuromolecular Med. 2017 Dec;19(4):480-492. (PMID: 28822073)
Mov Disord. 2012 Sep 15;27(11):1456-9. (PMID: 22893192)
J Neurosci. 2011 Jan 5;31(1):247-61. (PMID: 21209210)
Hum Mol Genet. 2014 Jun 1;23(11):2816-33. (PMID: 24603074)
Pathol Res Pract. 2014 Jun;210(6):357-62. (PMID: 24642369)
Cell Tissue Res. 2004 Oct;318(1):215-24. (PMID: 15503155)
Curr Opin Neurol. 2004 Aug;17(4):417-23. (PMID: 15247536)
PLoS One. 2010 Feb 23;5(2):e9367. (PMID: 20186336)
Inflammopharmacology. 2018 Apr;26(2):349-360. (PMID: 29027056)
Nat Med. 2015 Dec;21(12):1406-15. (PMID: 26646497)
Front Cell Neurosci. 2019 Jan 07;12:516. (PMID: 30666189)
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52. (PMID: 2841426)
J Biol Chem. 2005 Dec 23;280(51):42026-35. (PMID: 16243845)
J Parkinsons Dis. 2015;5(2):217-27. (PMID: 25757830)
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36; discussion 222. (PMID: 11983801)
Drugs. 2015 Feb;75(2):157-74. (PMID: 25559423)
Int J Mol Sci. 2020 Oct 03;21(19):. (PMID: 33023066)
N Engl J Med. 1985 May 30;312(22):1418-21. (PMID: 2581135)
Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):69-77. (PMID: 29972106)
Ageing Res Rev. 2021 May;67:101263. (PMID: 33540042)
Oxid Med Cell Longev. 2020 Oct 17;2020:7635291. (PMID: 33123315)
Ann Neurol. 2013 Apr;73(4):554-9. (PMID: 23424051)
J Neurochem. 2009 Sep;110(5):1445-56. (PMID: 19558452)
Oxid Med Cell Longev. 2016;2016:6705621. (PMID: 26770656)
FEBS J. 2015 Jun;282(11):2076-88. (PMID: 25712550)
J Exp Med. 2012 May 7;209(5):975-86. (PMID: 22508839)
Brain. 1999 Aug;122 ( Pt 8):1437-48. (PMID: 10430830)
J Exp Med. 2012 Apr 9;209(4):837-54. (PMID: 22473957)
Mov Disord. 2003 Jan;18(1):19-31. (PMID: 12518297)
Neurobiol Aging. 2017 Oct;58:163-179. (PMID: 28746897)
J Am Chem Soc. 2014 Mar 26;136(12):4551-6. (PMID: 24592866)
Neurochem Int. 2017 Mar;104:34-48. (PMID: 28082232)
Neurobiol Dis. 2016 Oct;94:169-78. (PMID: 27189756)
Cell Death Differ. 2012 Feb;19(2):257-66. (PMID: 21701498)
Lancet. 2017 Sep 16;390(10100):1211-1259. (PMID: 28919117)
Lancet Neurol. 2016 Nov;15(12):1257-1272. (PMID: 27751556)
Parkinsonism Relat Disord. 2018 May;50:104-107. (PMID: 29454662)
Front Pharmacol. 2021 Jan 27;11:618787. (PMID: 33584302)
J Neurosci. 2009 Jul 22;29(29):9210-8. (PMID: 19625511)
Neuron. 2019 Aug 21;103(4):627-641.e7. (PMID: 31255487)
Brain. 2016 Apr;139(Pt 4):1180-8. (PMID: 26920675)
Nature. 2005 Mar 31;434(7033):658-62. (PMID: 15800627)
Am J Epidemiol. 2003 Jun 1;157(11):1015-22. (PMID: 12777365)
Neuron. 2015 Jan 21;85(2):257-73. (PMID: 25611507)
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211. (PMID: 12498954)
J Neurochem. 2006 May;97(4):934-46. (PMID: 16573651)
Nat Rev Drug Discov. 2018 Nov;17(11):804-822. (PMID: 30262889)
Cell Res. 2016 Sep;26(9):1007-20. (PMID: 27573174)
Curr Opin Neurol. 2011 Aug;24(4):324-30. (PMID: 21725242)
Immunol Rev. 2018 Jan;281(1):8-27. (PMID: 29247995)
Antioxid Redox Signal. 2014 Jul 10;21(2):195-210. (PMID: 24251381)
Neurobiol Dis. 2015 Oct;82:185-199. (PMID: 26093169)
Neurology. 1990 Oct;40(10):1529-34. (PMID: 2215943)
Free Radic Biol Med. 2017 Nov;112:1-11. (PMID: 28709976)
Mol Neurodegener. 2018 May 11;13(1):21. (PMID: 29751824)
J Biol Chem. 2014 May 23;289(21):14458-69. (PMID: 24719325)
Mol Nutr Food Res. 2016 Oct;60(10):2161-2175. (PMID: 27296520)
Nat Rev Neurosci. 2003 Sep;4(9):727-38. (PMID: 12951565)
J Biol Chem. 2004 Apr 30;279(18):18614-22. (PMID: 14985362)
Lancet Neurol. 2011 Nov;10(11):1015-25. (PMID: 22014436)
Mol Cell Biol. 2004 Nov;24(22):9848-62. (PMID: 15509788)
Purinergic Signal. 2017 Jun;13(2):179-190. (PMID: 27848069)
Food Chem Toxicol. 2015 Sep;83:111-24. (PMID: 26066364)
Mov Disord. 2018 Oct;33(10):1601-1608. (PMID: 30145797)
Arch Neurol. 2008 Apr;65(4):514-9. (PMID: 18413475)
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94. (PMID: 17911161)
Nature. 1988 Jul 28;334(6180):345-8. (PMID: 2899295)
Nat Immunol. 2009 Mar;10(3):241-7. (PMID: 19221555)
Antioxid Redox Signal. 2009 Sep;11(9):2151-66. (PMID: 19243239)
Nat Rev Dis Primers. 2017 Mar 23;3:17013. (PMID: 28332488)
Acta Neurol Scand. 2016 Nov;134(5):314-326. (PMID: 26869347)
Brain. 2021 Aug 17;144(7):2047-2059. (PMID: 33704423)
Prog Neurobiol. 2013 Jul-Aug;106-107:17-32. (PMID: 23643800)
Proteomics. 2019 Sep;19(18):e1800311. (PMID: 30888116)
Physiol Rev. 2007 Jan;87(1):245-313. (PMID: 17237347)
Mol Neurobiol. 2016 Jul;53(5):3326-3337. (PMID: 26081143)
Mov Disord. 2019 Jun;34(6):801-811. (PMID: 31091353)
Mol Neurobiol. 2013 Apr;47(2):537-51. (PMID: 22941029)
Lancet Neurol. 2009 May;8(5):464-74. (PMID: 19375664)
Cell. 2009 Feb 20;136(4):731-45. (PMID: 19239892)
Nat Rev Microbiol. 2009 Feb;7(2):99-109. (PMID: 19148178)
J Clin Invest. 2009 Jan;119(1):182-92. (PMID: 19104149)
Biochim Biophys Acta. 2013 May;1832(5):618-25. (PMID: 23376588)
Neurol Clin. 1992 May;10(2):317-29. (PMID: 1584176)
J Neuroinflammation. 2016 Jun 30;13(1):174. (PMID: 27364890)
Neuroepidemiology. 1996;15(4):201-7. (PMID: 8817502)
Nat Cell Biol. 2014 Dec;16(12):1180-91. (PMID: 25402683)
J Cell Biol. 2008 Dec 1;183(5):795-803. (PMID: 19029340)
Neuron. 2002 May 16;34(4):521-33. (PMID: 12062037)
Oxid Med Cell Longev. 2019 Apr 28;2019:6527638. (PMID: 31182996)
Sci Transl Med. 2019 Jul 24;11(502):. (PMID: 31341063)
Ann N Y Acad Sci. 2008 Dec;1147:395-412. (PMID: 19076459)
Brain. 1991 Oct;114 ( Pt 5):2283-301. (PMID: 1933245)
Neurochem Int. 2012 Mar;60(4):400-8. (PMID: 22265823)
Nat Cell Biol. 2010 Feb;12(2):119-31. (PMID: 20098416)
NPJ Parkinsons Dis. 2018 Dec 6;4:35. (PMID: 30534585)
Acta Pharm Sin B. 2022 Nov;12(11):4011-4039. (PMID: 36386472)
Free Radic Biol Med. 2012 Aug 15;53(4):983-92. (PMID: 22687462)
Cell Death Differ. 2017 Dec;24(12):2210. (PMID: 29027992)
J Parkinsons Dis. 2013;3(4):415-59. (PMID: 24270242)
Neurology. 2000 Nov 14;55(9):1358-63. (PMID: 11087781)
JAMA Neurol. 2013 Jul;70(7):859-66. (PMID: 23689920)
J Neurosci Res. 2015 Sep;93(9):1413-22. (PMID: 25824456)
Exp Neurol. 2008 Jan;209(1):22-7. (PMID: 17949715)
Mutat Res Rev Mutat Res. 2018 Oct - Dec;778:72-78. (PMID: 30454685)
Cell Death Dis. 2014 Jul 24;5:e1350. (PMID: 25058424)
J Neural Transm (Vienna). 2016 Nov;123(11):1301-1307. (PMID: 27250986)
Eur J Pharmacol. 2021 Oct 15;909:174413. (PMID: 34391769)
Signal Transduct Target Ther. 2021 Jan 29;6(1):34. (PMID: 33514686)
Hum Mol Genet. 2010 Oct 1;19(19):3734-46. (PMID: 20639397)
Int J Mol Sci. 2012;13(9):11783-11803. (PMID: 23109883)
J Neurochem. 2006 Jun;97(6):1634-58. (PMID: 16805774)
J Neurochem. 2003 Jul;86(1):165-72. (PMID: 12807436)
Biochim Biophys Acta. 2015 Apr;1850(4):794-801. (PMID: 25484314)
Annu Rev Med. 2018 Jan 29;69:437-449. (PMID: 29106805)
Parkinsonism Relat Disord. 2017 Feb;35:36-41. (PMID: 27890451)
N Engl J Med. 2020 May 14;382(20):1926-1932. (PMID: 32402162)
Anat Rec (Hoboken). 2018 Jun;301(6):1115-1125. (PMID: 29350822)
Neurosci Lett. 2009 May 1;454(3):187-92. (PMID: 19429081)
J Cell Biol. 2004 Apr;165(1):123-33. (PMID: 15078903)
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S30-S33. (PMID: 28780180)
Hum Mol Genet. 2017 May 1;26(9):1656-1669. (PMID: 28334751)
Am J Hum Genet. 2011 Sep 9;89(3):398-406. (PMID: 21907011)
Mov Disord. 2011 Oct;26 Suppl 3:S42-80. (PMID: 22021174)
Mov Disord. 2006 Sep;21(9):1506-10. (PMID: 16758483)
Neurotherapeutics. 2014 Jan;11(1):78-91. (PMID: 24288035)
Mov Disord. 2012 Apr 15;27(5):617-26. (PMID: 22508280)
J Neuroendocrinol. 2019 May;31(5):e12684. (PMID: 30614568)
Aging (Albany NY). 2019 Apr 4;11(7):1934-1964. (PMID: 30958793)
Evid Based Complement Alternat Med. 2015;2015:730121. (PMID: 26681969)
Acta Neuropathol. 2019 Oct;138(4):535-550. (PMID: 31254094)
Curr Opin Neurol. 2012 Aug;25(4):433-47. (PMID: 22691758)
Neurotox Res. 2020 Mar;37(3):491-507. (PMID: 31823227)
Prog Lipid Res. 2010 Oct;49(4):420-8. (PMID: 20580911)
Acta Neuropathol. 2000 Aug;100(2):111-4. (PMID: 10963356)
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6. (PMID: 19892735)
Mov Disord. 2005 Feb;20(2):151-7. (PMID: 15390035)
Nature. 2006 Oct 19;443(7113):787-95. (PMID: 17051205)
Adv Pharmacol Sci. 2011;2011:572634. (PMID: 21941533)
Nat Rev Neurol. 2014 Dec;10(12):708-22. (PMID: 25385334)
Nat Chem Biol. 2020 Mar;16(3):278-290. (PMID: 32080625)
PLoS Biol. 2010 Jan 26;8(1):e1000298. (PMID: 20126261)
JAMA Neurol. 2017 Feb 01;74(2):216-224. (PMID: 27942720)
Neurology. 1988 Aug;38(8):1285-91. (PMID: 3399080)
J Neurochem. 2013 Aug;126(4):541-9. (PMID: 23506423)
Ageing Res Rev. 2018 Mar;42:72-85. (PMID: 29288112)
Expert Opin Emerg Drugs. 2013 Mar;18(1):39-53. (PMID: 23373820)
Neurosci Lett. 1994 Oct 24;180(2):147-50. (PMID: 7700568)
Acta Neurol Scand. 2015 Aug;132(2):73-8. (PMID: 25765080)
Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1223-9. (PMID: 23700916)
J Biol Chem. 2006 Jan 6;281(1):334-40. (PMID: 16260788)
Food Chem Toxicol. 2020 Oct;144:111644. (PMID: 32763437)
J Neuroinflammation. 2019 Dec 3;16(1):250. (PMID: 31796095)
Mov Disord. 2014 Sep;29(10):1244-51. (PMID: 24996051)
Front Mol Neurosci. 2018 Jan 19;10:455. (PMID: 29403352)
Lancet Neurol. 2006 Aug;5(8):677-87. (PMID: 16857573)
Brain. 2020 May 1;143(5):1462-1475. (PMID: 32380543)
J Neuroinflammation. 2018 Jul 12;15(1):205. (PMID: 30001736)
Neurology. 1996 Apr;46(4):1044-50. (PMID: 8780088)
Hum Mol Genet. 2004 May 1;13(9):935-44. (PMID: 15016765)
Antioxidants (Basel). 2019 Dec 31;9(1):. (PMID: 31906147)
N Engl J Med. 2022 Aug 4;387(5):421-432. (PMID: 35921451)
Neuroscience. 1996 May;72(2):355-63. (PMID: 8737406)
J Neurosci. 2013 Jun 12;33(24):10154-64. (PMID: 23761910)
Hum Mol Genet. 2012 May 1;21(9):1931-44. (PMID: 22228096)
J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):409-15. (PMID: 22952329)
Lancet Neurol. 2016 Feb;15(2):154-165. (PMID: 26725544)
Nat Chem Biol. 2017 Jan;13(1):81-90. (PMID: 27842066)
J Neural Transm (Vienna). 1996;103(8-9):1077-81. (PMID: 9013395)
Redox Biol. 2021 Jan;38:101789. (PMID: 33212416)
Mol Neurodegener. 2008 Dec 29;3:21. (PMID: 19114014)
Cell Mol Neurobiol. 2015 Jul;35(5):661-8. (PMID: 25656940)
Neurobiol Dis. 2017 Sep;105:84-98. (PMID: 28576704)
Mov Disord. 2016 Sep;31(9):1366-72. (PMID: 27430123)
Int J Mol Sci. 2024 May 01;25(9):. (PMID: 38732162)
Science. 1983 Feb 25;219(4587):979-80. (PMID: 6823561)
Neurosci Lett. 1995 Jun 30;193(2):129-32. (PMID: 7478158)
J Alzheimers Dis. 2019;72(3):823-833. (PMID: 31658061)
J Neurochem. 2008 Oct;107(2):303-16. (PMID: 18691382)
Cell. 2006 Oct 20;127(2):397-408. (PMID: 17055439)
Lancet. 2014 Sep 27;384(9949):1196-205. (PMID: 24928805)
Neurology. 2016 Feb 9;86(6):566-76. (PMID: 26764028)
Behav Brain Res. 2015 Sep 15;291:1-11. (PMID: 25975173)
Eur J Neurosci. 2015 May;41(9):1113-25. (PMID: 25761903)
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S200-4. (PMID: 20082990)
Biochem J. 2016 Oct 15;473(20):3563-3580. (PMID: 27503909)
Brain. 2020 Dec 1;143(12):3717-3733. (PMID: 33118032)
Ther Adv Neurol Disord. 2020 Mar 06;13:1756286420911296. (PMID: 32201505)
Nat Rev Neurosci. 2017 Mar 17;18(4):251-259. (PMID: 28303016)
Front Neurosci. 2019 Aug 07;13:839. (PMID: 31440136)
Neurology. 2013 Jan 15;80(3):276-81. (PMID: 23319473)
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9040-5. (PMID: 26134396)
Prog Neurobiol. 2019 Jun;177:73-93. (PMID: 30219247)
Biomed Pharmacother. 2021 Aug;140:111556. (PMID: 34087694)
Oxid Med Cell Longev. 2013;2013:157857. (PMID: 24379900)
Hum Mol Genet. 2014 Jun 1;23(11):2802-15. (PMID: 24399444)
Neuron. 2003 Sep 11;39(6):889-909. (PMID: 12971891)
Free Radic Res. 2018 Dec;52(11-12):1371-1386. (PMID: 30693838)
Mol Neurobiol. 2017 Apr;54(3):2361-2372. (PMID: 26957304)
Sci Rep. 2013;3:1393. (PMID: 23462811)
Hum Mol Genet. 2014 Jun 1;23(11):2791-801. (PMID: 24334770)
Brain Behav Immun. 2022 Mar;101:194-210. (PMID: 35032575)
Nat Commun. 2020 Mar 6;11(1):1251. (PMID: 32144268)
Antioxidants (Basel). 2024 Oct 12;13(10):. (PMID: 39456479)
Nat Neurosci. 2020 Mar;23(3):327-336. (PMID: 32066981)
J Mol Neurosci. 2020 Jul;70(7):1038-1049. (PMID: 32207050)
Front Cell Neurosci. 2018 Aug 06;12:247. (PMID: 30127724)
Mol Cell Biol. 2015 Aug;35(16):2740-51. (PMID: 26031332)
Neural Regen Res. 2019 Oct;14(10):1814-1822. (PMID: 31169200)
PLoS One. 2012;7(1):e29935. (PMID: 22253830)
Acta Neuropathol Commun. 2021 Mar 22;9(1):47. (PMID: 33752749)
Trends Mol Med. 2022 Apr;28(4):258-269. (PMID: 35260343)
Neuroimage. 2012 Sep;62(3):1593-9. (PMID: 22634862)
Neurology. 2015 Nov 10;85(19):1670-9. (PMID: 26468408)
Neurobiol Dis. 2015 Jun;78:172-95. (PMID: 25836420)
Mov Disord. 2018 Aug;33(8):1248-1266. (PMID: 29570866)
J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):96-101. (PMID: 2313313)
J Parkinsons Dis. 2015;5(4):699-713. (PMID: 26407041)
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):378-83. (PMID: 19966284)
Mov Disord. 2014 Jul;29(8):999-1009. (PMID: 24898698)
Nature. 2019 Jul;571(7766):565-569. (PMID: 31316206)
Sci Rep. 2016 Nov 03;6:36410. (PMID: 27808258)
CNS Drugs. 2011 Dec 1;25(12):1061-71. (PMID: 22133327)
Sci Rep. 2016 Oct 06;6:34477. (PMID: 27708338)
Sci Rep. 2017 May 3;7(1):1398. (PMID: 28469157)
Biomed Pharmacother. 2018 Oct;106:1236-1242. (PMID: 30119192)
Biochem Biophys Res Commun. 2018 Sep 5;503(2):1042-1048. (PMID: 29935183)
Adv Neurobiol. 2017;14:3-30. (PMID: 28353276)
Oncotarget. 2016 Oct 18;7(42):68292-68302. (PMID: 27626170)
Neuron. 2011 Oct 6;72(1):57-71. (PMID: 21982369)
Front Neurosci. 2018 Feb 20;12:73. (PMID: 29515352)
Neuron. 2002 Jul 18;35(2):219-22. (PMID: 12160740)
Cell. 2012 May 25;149(5):1060-72. (PMID: 22632970)
Cell Stem Cell. 2018 Jul 05;23(1):123-131.e6. (PMID: 29979986)
Brain Behav Immun. 2018 Jul;71:93-107. (PMID: 29649522)
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6637-42. (PMID: 25969509)
Life Sci. 2012 Jun 6;90(21-22):874-82. (PMID: 22575822)
Cell Death Dis. 2021 Jan 13;12(1):81. (PMID: 33441545)
Chin Med. 2012 Jan 21;7(1):1. (PMID: 22264378)
Nat Cell Biol. 2007 Nov;9(11):1243-52. (PMID: 17906618)
J Neurosci. 2019 Sep 11;39(37):7291-7305. (PMID: 31358653)
Sci Transl Med. 2018 Oct 31;10(465):. (PMID: 30381407)
Front Neurol. 2014 Dec 15;5:242. (PMID: 25566170)
Ann N Y Acad Sci. 2004 Dec;1035:104-16. (PMID: 15681803)
J Exp Med. 2019 Jun 3;216(6):1411-1430. (PMID: 31036561)
Signal Transduct Target Ther. 2021 Feb 24;6(1):77. (PMID: 33623004)

Keywords: Parkinson’s disease (PD); ferroptosis; gut dysbiosis; medicinal plants; mitochondrial dysfunction; neuroinflammation; oxidative stress

0 (alpha-Synuclein)

Date Created: 20250712 Date Completed: 20250712 Latest Revision: 20250716

20250717

PMC12250488

10.3390/ijms26136416

40650193